Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Nephrology
•
Transplant nephrology
What is your approach for patients with a history of nephrolithiasis who are being evaluated for living kidney donation?
Related Questions
Is there a BMI cutoff for which you no longer recommend kidney transplantation in a patient with end stage kidney disease and obesity?
How frequently do you recommend skin cancer screens in your patients with kidney transplants who are on immunosuppression?
How do you counsel patients who experience diarrhea from mycophenolate mofetil (Cellcept)?
Do you require lupus patients with ESKD or advanced CKD to be on minimal immunosuppression around the time of kidney transplantation?
Would you order a repeat DEXA scan 1 year later for a kidney transplant patient who had an initial DEXA scan within the first 6 months post-transplant showing osteopenia but no history of fractures, and who has been stable on glucocorticoid-free immunosuppressive therapy?
What is the role of APOL1 genotyping in the evaluation of a living kidney donor?
How do you approach treatment for patients with proliferative glomerulonephritis with monoclonal IgG deposits (PGNMID) with end-stage renal disease who are considering kidney transplant?
What is your approach to management of tremors in a kidney transplant recipient who is taking a CNI for immunosuppression?
Would you consider a BRCA carrier patient for kidney transplantation?
Do you recommend switching from tacrolimus to cyclosporine in a kidney transplant patient diagnosed with PTLD?
